One of the major risk factors of developing hepatocellular adenoma (HCA) is the use of oral contraceptives, which stimulate liver expressed estrogen and androgen receptors, predominantly in women between 15 and 45 years of age [1, 2]. This evidence concerns the gene AR and hepatocellular adenoma.